Skip to content

Main Navigation

Omniabio
  • CDMO Services
    • Services overview
    • Platform Leadership
    • Extensive Expertise
    • Case Studies
  • Manufacturing Infrastructure
    • Infrastructure Overview
    • Facilities by project stage
  • News
    • News Releases
    • OmniaBio in the News
    • Recent Highlights
  • Events
  • Careers
  • Contact Us
  • Mailing list

OmniaBio Inc. announces private investor.

Posted on December 1, 2022 by jpearl

Post navigation

 NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada.Funding from Ontario Government for OmniaBio. 
© 2023 OmniaBio Inc.
Privacy Policy